Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant
Daniel, A., d' Emden, M., & Duncan, E. (2013) Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant. Internal Medicine Journal, 43(3), pp. 345-347.
A Caucasian male aged 15 years presented with 2 years accelerated linear growth. He was 202 cm tall at presentation, with calculated mid-parental height of 173 cm. There were no features of hypopituitarism or acral growth. His visual fields and optic discs were normal...
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||angiopeptin, pegvisomant, somatomedin C, adolescent, androgen therapy, clinical article, gigantism, growth plate, human, hypophysis adenoma, hypophysis disease, letter, male, nuclear magnetic resonance imaging, pituitary gigantism, priority journal, Hormone Antagonists, Human Growth Hormone, Humans, Membrane Proteins, Treatment Outcome|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Deposited On:||29 Mar 2016 00:35|
|Last Modified:||30 Mar 2016 01:51|
Repository Staff Only: item control page